B. Di Iorio et al., Successful use of central venous catheter as permanent hemodialysis access: 84-month follow-up in Lucania, BLOOD PURIF, 19(1), 2001, pp. 39-43
Cuffed tunneled venous access catheters are commonly used for temporary and
permanent access in hemodialysis (HD) patients. These catheters serve an e
ssential role in providing permanent access in subjects in whom all other a
ccess options have been exhausted. The predominant complications are cathet
er thrombosis, catheter fibrin sheating and infection. The aim of this stud
y was to evaluate long-term survival and complications of permanent venous
catheters (PVC) placed for the purpose of HD during the period from January
1992 to December 1998, at the Dialysis Units of Lucania (a southern Italia
n region). A total of 98 PVC were placed in 88 patients during this period.
The catheters used were of three types: (a) 72 VasCath Soft Cell catheters
(Bard Instrument Company, Toronto, Ont., Canada); (b) 22 PermCath catheter
s (Quinton Instrument Company, Seattle, Wash., USA), and ((c)) 4 Tesio cath
eters (Bellco SpA, Mirandola, Italy). Survival curves of catheters were cal
culated using the Kaplan-Meier product-limit estimator. The patient surviva
l was 60% at the 78th month. Actually, 52 patients (27 males, 25 females) a
re still alive: 15 (26.9%) of these patients have diabetes mellitus and ? h
as been transplanted. The actuarial survival rate of PVC was 89% in the who
le population studied and 82% in subjects alive after 84 months. Twenty-fiv
e patients (28.4%) had PVC as the first reliable vascular access. Long-term
complications occurred 27 times (1 episode every 44.81 month/ patient) as:
breakage (3.1%); thrombosis (10.2%); displacement (2.0%); subcutaneous tun
nel bleeding (3.1%); inadequate blood flow (7.1%), and infection (10.2%). I
n conclusion, our data confirm that PVC might represent an effective long-t
erm blood access route for HD. Again, PVC are getting the access of choice
for selected patients (i.e., older subjects with cardiovascular diseases an
d cancer patients) and are enjoying a dramatic increase in use for subjects
who are terrified of repetitive venopuncture. Copyright (C) 2001 S. Karger
AG, Basel.